Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene therapy of the typical multidrug resistance phenotype of cancers: a new hope?

Seminars in oncology - 1 Dec 2005

Labialle Stëphane, Dayan Guila, Michaud Mickaél, Barakat Stëphane, Rigal Dominque, Baggetto Loris G

Abstract excerpt

The multidrug resistance (MDR) phenotype of cancers has generated a large amount of research, owing to its constant fatal clinical outcome. Many studies have focused on the discovery of chemomodulators; however, in spite of this huge effort, the side effects that these products induce, and their additive toxicity when used in the presence of anticancer drugs, have led to the disaffection of the pharmaceutical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Drug Resistance, Multiple

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, MDR

Share to Genetic Therapy

Share to Neoplasms

Share to Phenotype

Share to RNA Interference

Source

Identifiers

PMID: 16338424
DOI: 10.1053/j.seminoncol.2005.09.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene therapy of the typical multidrug resistance phenotype of cancers: a new hope?PMID 16338424Read ↗

Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter.Semantic proximity Read ↗

Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancersSemantic proximity Read ↗

Therapeutic strategies involving the multidrug resistance phenotype: the MDR1 gene as target, chemoprotectant, and selectable marker in gene therapy.Semantic proximity Read ↗

Multidrug resistance: molecular mechanisms and clinical relevanceSemantic proximity Read ↗

Multidrug Resistance: Are We Still Afraid of the Big Bad WolfSemantic proximity Read ↗

New mechanisms of multidrug resistance: an introduction to the Cancer Drug Resistance special collectionSemantic proximity Read ↗

From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significanceSemantic proximity Read ↗

Overcoming multidrug resistance through targeting ABC transporters: lessons for drug discoverySemantic proximity Read ↗

Targeting oncogenes and tumor suppressors genes to mitigate chemoresistance.Semantic proximity Read ↗

Multidrug resistance: overcoming the good, the bad, and the ugly.Semantic proximity Read ↗

New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in CancerSemantic proximity Read ↗

Modulation of multidrug resistance: at the threshold.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.